Tablet Conveyor for Automated Handling of Fragile Products
The piFLOW from Piab is a dedicated tablet conveyor suitable for transporting up to four million tablets per hour.
piFLOW from Piab is a dedicated tablet conveyor for the automated handling of tablets and other fragile products. piFLOW is suitable for transporting up to four million tablets per hour and is primarily targeted at the pharmaceutical industry’s tablets and capsules. The conveyor will safely transfer tablets between various processing units, including tablet presses, coating drums, and blister packaging lines, avoiding risk of damage to the tablets.
At the core of piFLOW is the proprietary piGENTLE, an innovative technology (patent pending) that maintains a gentle tablet flow by regulating the feed pressure of the pump, ensuring that tablets, capsules, or other fragile products are handled as delicately as possible. piFLOW conveyors for powder and bulk materials are developed to meet the demands regarding operational safety and hygiene within the pharmaceutical, food, and chemical industries.
Source: Piab
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
